Current Investigations


  • All
  • Antitrust Litigation
  • Consumer Protection Litigation
  • Securities Litigation
  • Shareholder Derivative Litigation
  • Shareholder Merger Litigation
  • Employment Litigation

20 Mar 2024

agilon health, inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

18 Mar 2024

Innoviz Technologies Ltd.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Innoviz Technologies Ltd. ("Innoviz" or the "Company") (NASDAQ: INVZ) and reminds investors of the May 14, 2024 deadline to seek the role of lead plaintiff ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

14 Mar 2024

Luna Innovations Incorporated

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Luna Innovations Incorporated ("Luna" or the "Company") (NASDAQ: LUNA) and reminds investors of the May 31, 2024 deadline to seek the role of lead ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

14 Mar 2024

Anavex Life Sciences Corporation

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corporation ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the May 13, 2024 deadline to seek the role of ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

12 Mar 2024

iRobot Corporation

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRobot Corporation ("iRobot" or the "Company") (NASDAQ: IRBT) and reminds investors of the May 7, 2024 deadline to seek the role of lead plaintiff ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

01 Mar 2024

Ventyx Biosciences, Inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors of the April 30, 2024 deadline to seek the role of lead plaintiff ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

29 Feb 2024

Nextdoor Holdings, Inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nextdoor Holdings, Inc. ("Nextdoor" or the "Company") (NYSE: KIND) and reminds investors of the April 29, 2024 deadline to seek the role of lead plaintiff ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

28 Feb 2024

The Children's Place, Inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Children's Place, Inc. ("The Children's Place" or the "Company") (NASDAQ: PLCE) and reminds investors of the April 29, 2024 deadline to seek the ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

27 Feb 2024

World Acceptance Corporation

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In World Acceptance To Contact Him Directly To Discuss Their Options If you suffered significant losses in World Acceptance stock or options and would ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

26 Feb 2024

Palo Alto Networks, Inc.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Palo Alto Networks To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Palo Alto Networks ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

22 Feb 2024

Fluence Energy, Inc.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Fluence Energy To Contact Him Directly To Discuss Their Options If you suffered significant losses in Fluence Energy stock or options and would like ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

20 Feb 2024

SSR Mining Inc.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SSR Mining Inc. ("SSR Mining" or the "Company") (NASDAQ: SSRM) and reminds investors of the May 17, 2024 deadline to seek the role of lead plaintiff ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

16 Feb 2024

Temenos AG

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Temenos To Contact Him Directly To Discuss Their Options If you suffered significant losses in Temenos stock or options and would like to discuss ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

19 Sep 2023

Lordstown Motors Corp.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Lordstown To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

26 Jan 2023

Argo Blockchain plc

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Argo To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

06 Dec 2022

NewAge, Inc.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In NewAge To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

18 Oct 2021

Revance Therapeutics, Inc.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

06 May 2021

Peloton Interactive Inc. (PTON)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Peloton To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...

Robert W. Killorin, James M. Wilson, Jr. at New York office

Read more

23 Sep 2020

Teva Pharmaceutical Industries Limited (TEVA)

TEVA DEADLINE ALERT Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in Teva stock or options ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

13 May 2019

Amneal Pharmaceuticals, Inc. (AMRX)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Amneal ...

James M. Wilson, Jr., Robert W. Killorin at New York office

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania